Lisa L. von Moltke
Department of Pharmacology and Experimental Therapeutics
Tufts University School of Medicine
Boston
MA 02111
USA
Name/email consistency: high
- Interaction of triazolam and ketoconazole in P-glycoprotein-deficient mice. von Moltke, L.L., Granda, B.W., Grassi, J.M., Perloff, M.D., Vishnuvardhan, D., Greenblatt, D.J. Drug Metab. Dispos. (2004)
- Inhibition of human cytochromes P450 by components of Ginkgo biloba. von Moltke, L.L., Weemhoff, J.L., Bedir, E., Khan, I.A., Harmatz, J.S., Goldman, P., Greenblatt, D.J. J. Pharm. Pharmacol. (2004)
- Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopram. von Moltke, L.L., Greenblatt, D.J., Giancarlo, G.M., Granda, B.W., Harmatz, J.S., Shader, R.I. Drug Metab. Dispos. (2001)
- Potent mechanism-based inhibition of human CYP3A in vitro by amprenavir and ritonavir: comparison with ketoconazole. von Moltke, L.L., Durol, A.L., Duan, S.X., Greenblatt, D.J. Eur. J. Clin. Pharmacol. (2000)
The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.








